Anbio Biotechnology
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Anbio Biotechnology
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
/ 
Others were interested in
Frequently asked questions
To buy Anbio Biotechnology stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Anbio Biotechnology by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Anbio Biotechnology is NNNN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Anbio Biotechnology has its primary listing on NASDAQ (Small cap). You can trade Anbio Biotechnology with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Anbio Biotechnology is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Anbio Biotechnology as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Anbio Biotechnology.